Watchlist
Loading...
Dow Jones34070.42-370.46 -1.08%NASDAQ13223.98-245.14 -1.82%S&P 5004330.00-72.20 -1.64%
US Stock MarketDetailed Quotes

TCBP TC BioPharm

Watchlist
0.4270 -0.0263-5.80% Close 09/21 16:00 ET
0.4300+0.0030+0.70% Post 18:28 ET
0.4500High0.4001Low199.23KVolume

TC BioPharm Key Stats

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY
Hide blank lines
(FY)2022/12/31
(FY)2021/12/31
(Q4)2021/12/31
(Q3)2021/09/30
(FY)2020/12/31
(Q4)2020/12/31
(FY)2019/12/31
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-160.35%-14.53M
-62.62%-5.58M
-67.45%-2.55M
-1.09M
49.00%-3.43M
-1.52M
-6.73M
Net income from continuing operations
79.25%-3.11M
-126.00%-14.98M
-168.52%-4.52M
---7.3M
3.83%-6.63M
---1.68M
---6.89M
Operating gains losses
-475.26%-15.94M
224,465.20%4.25M
45,841.19%271.05K
--3.97M
-97.40%1.89K
--590
--72.69K
Depreciation and amortization
-5.74%966.17K
-4.66%1.03M
-6.78%250.35K
--249.31K
18.88%1.08M
--268.56K
--904.47K
Other non cash items
107.43%7.13M
1,081.49%3.44M
2,692.96%1.92M
--1.15M
14.80%291.03K
--68.81K
--253.51K
Change In working capital
-2,410.61%-5.83M
-402.61%-232.08K
14.28%-410.55K
---270.81K
104.23%76.69K
---478.92K
---1.81M
-Change in receivables
93.66%-37.5K
-134.22%-591.62K
-953.54%-447.53K
---244.18K
569.96%1.73M
--52.43K
--258.05K
-Change in payables and accrued expense
-183.16%-1.94M
616.02%2.34M
1,548.98%531.65K
--468.04K
884.71%326.56K
---36.69K
---41.62K
-Change in other working capital
-94.30%-3.84M
0.00%-1.98M
0.00%-494.67K
---494.66K
2.56%-1.98M
---494.67K
---2.03M
Cash from discontinued investing activities
Operating cash flow
-160.35%-14.53M
-62.62%-5.58M
-67.45%-2.55M
---1.09M
49.00%-3.43M
---1.52M
---6.73M
Investing cash flow
Cash flow from continuing investing activities
-116.58%-310.2K
30.13%-143.22K
1.87%-52.04K
-30.27K
90.67%-204.99K
-53.03K
-2.2M
Net PPE purchase and sale
-827.03%-185.71K
42.60%-20.03K
-80.48%-8.75K
---9.34K
98.28%-34.9K
---4.85K
---2.03M
Net intangibles purchase and sale
-1.05%-124.49K
27.57%-123.19K
10.15%-43.29K
---20.94K
-0.02%-170.09K
---48.18K
---170.06K
Cash from discontinued investing activities
Investing cash flow
-116.58%-310.2K
30.13%-143.22K
1.87%-52.04K
---30.27K
90.67%-204.99K
---53.03K
---2.2M
Financing cash flow
Cash flow from continuing financing activities
174.19%17.89M
90.22%6.53M
2,538.45%2.61M
2.36M
4.78%3.43M
-107.22K
3.27M
Net issuance payments of debt
-153.93%-3.38M
1,607.73%6.26M
2,538.45%2.61M
--2.36M
-406.39%-415.27K
---107.22K
--135.54K
Net common stock issuance
1,081.97%3.37M
-92.69%285.11K
100.76%1
--0
24.24%3.9M
---131
--3.14M
Proceeds from stock option exercised by employees
--18.81M
--0
----
----
--0
----
----
Net other financing activities
-4,193.96%-908.6K
60.28%-21.16K
--0
--0
---53.27K
--131
----
Cash from discontinued financing activities
Financing cash flow
174.19%17.89M
90.22%6.53M
2,538.45%2.61M
--2.36M
4.78%3.43M
---107.22K
--3.27M
Net cash flow
Beginning cash position
109.45%1.57M
-21.80%748.02K
-36.18%1.55M
--287.99K
-85.66%956.5K
--2.43M
--6.67M
Current changes in cash
280.92%3.05M
487.67%800.89K
100.93%15.62K
--1.24M
96.35%-206.59K
---1.68M
---5.65M
Effect of exchange rate changes
972.22%190.65K
1,040.30%17.78K
150.17%296
--18.76K
96.95%-1.89K
---590
---61.92K
End cash Position
206.89%4.81M
109.45%1.57M
109.45%1.57M
--1.55M
-21.80%748.02K
--748.02K
--956.5K
Free cash flow
-160.21%-14.9M
-57.40%-5.72M
-65.11%-2.6M
---1.12M
59.26%-3.64M
---1.57M
---8.93M
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
--
(FY)2022/12/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30(FY)2020/12/31(Q4)2020/12/31(FY)2019/12/31
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -160.35%-14.53M-62.62%-5.58M-67.45%-2.55M-1.09M49.00%-3.43M-1.52M-6.73M
Net income from continuing operations 79.25%-3.11M-126.00%-14.98M-168.52%-4.52M---7.3M3.83%-6.63M---1.68M---6.89M
Operating gains losses -475.26%-15.94M224,465.20%4.25M45,841.19%271.05K--3.97M-97.40%1.89K--590--72.69K
Depreciation and amortization -5.74%966.17K-4.66%1.03M-6.78%250.35K--249.31K18.88%1.08M--268.56K--904.47K
Other non cash items 107.43%7.13M1,081.49%3.44M2,692.96%1.92M--1.15M14.80%291.03K--68.81K--253.51K
Change In working capital -2,410.61%-5.83M-402.61%-232.08K14.28%-410.55K---270.81K104.23%76.69K---478.92K---1.81M
-Change in receivables 93.66%-37.5K-134.22%-591.62K-953.54%-447.53K---244.18K569.96%1.73M--52.43K--258.05K
-Change in payables and accrued expense -183.16%-1.94M616.02%2.34M1,548.98%531.65K--468.04K884.71%326.56K---36.69K---41.62K
-Change in other working capital -94.30%-3.84M0.00%-1.98M0.00%-494.67K---494.66K2.56%-1.98M---494.67K---2.03M
Cash from discontinued investing activities
Operating cash flow -160.35%-14.53M-62.62%-5.58M-67.45%-2.55M---1.09M49.00%-3.43M---1.52M---6.73M
Investing cash flow
Cash flow from continuing investing activities -116.58%-310.2K30.13%-143.22K1.87%-52.04K-30.27K90.67%-204.99K-53.03K-2.2M
Net PPE purchase and sale -827.03%-185.71K42.60%-20.03K-80.48%-8.75K---9.34K98.28%-34.9K---4.85K---2.03M
Net intangibles purchase and sale -1.05%-124.49K27.57%-123.19K10.15%-43.29K---20.94K-0.02%-170.09K---48.18K---170.06K
Cash from discontinued investing activities
Investing cash flow -116.58%-310.2K30.13%-143.22K1.87%-52.04K---30.27K90.67%-204.99K---53.03K---2.2M
Financing cash flow
Cash flow from continuing financing activities 174.19%17.89M90.22%6.53M2,538.45%2.61M2.36M4.78%3.43M-107.22K3.27M
Net issuance payments of debt -153.93%-3.38M1,607.73%6.26M2,538.45%2.61M--2.36M-406.39%-415.27K---107.22K--135.54K
Net common stock issuance 1,081.97%3.37M-92.69%285.11K100.76%1--024.24%3.9M---131--3.14M
Proceeds from stock option exercised by employees --18.81M--0----------0--------
Net other financing activities -4,193.96%-908.6K60.28%-21.16K--0--0---53.27K--131----
Cash from discontinued financing activities
Financing cash flow 174.19%17.89M90.22%6.53M2,538.45%2.61M--2.36M4.78%3.43M---107.22K--3.27M
Net cash flow
Beginning cash position 109.45%1.57M-21.80%748.02K-36.18%1.55M--287.99K-85.66%956.5K--2.43M--6.67M
Current changes in cash 280.92%3.05M487.67%800.89K100.93%15.62K--1.24M96.35%-206.59K---1.68M---5.65M
Effect of exchange rate changes 972.22%190.65K1,040.30%17.78K150.17%296--18.76K96.95%-1.89K---590---61.92K
End cash Position 206.89%4.81M109.45%1.57M109.45%1.57M--1.55M-21.80%748.02K--748.02K--956.5K
Free cash flow -160.21%-14.9M-57.40%-5.72M-65.11%-2.6M---1.12M59.26%-3.64M---1.57M---8.93M
Currency Unit GBPGBPGBPGBPGBPGBPGBP
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory Notes----